The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Derivation and validation of a prediction scale for response to PD-1 monotherapy.
 
Adi Nosrati
No Relationships to Disclose
 
Simone M. Goldinger
Consulting or Advisory Role - Bristol-Myers Squibb; MDS Nordion; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MDS Nordion; Novartis; Roche
 
Katy K. Tsai
No Relationships to Disclose
 
Kimberly Loo
No Relationships to Disclose
 
Paul Tumeh
No Relationships to Disclose
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Novartis
 
Alain Patrick Algazi
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Oncosec (Inst)
 
Mitchell P. Levesque
No Relationships to Disclose
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)